Normofludil (Acetylcysteine)

Acetylcysteine breaks disulfide bonds in mucin proteins, decreasing the viscosity of mucus and facilitating its removal from the lungs. Additionally, it provides cysteine for the synthesis of glutathione, a key intracellular antioxidant that helps neutralise toxic metabolites, especially those formed during acetaminophen metabolism.

The appropriate dose of Normofludil is determined by the prescribing clinician based on the patient’s condition, age, weight and renal function. Dosage regimens can differ between chronic respiratory use and acute overdose treatment, so the prescriber will set the exact schedule.

Safety data for acetylcysteine in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks before prescribing. If treatment is necessary, it should be undertaken under medical supervision, and breastfeeding mothers should discuss potential exposure with their doctor.

To request Normofludil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and any necessary import documentation.

Normofludil (acetylcysteine) is a direct‑acting mucolytic that reduces mucus viscosity by breaking disulfide bonds, whereas agents such as carbocisteine act by modifying mucus production. Acetylcysteine also uniquely replenishes glutathione, giving it an additional antioxidant benefit, especially useful in acetaminophen overdose.

Normofludil should be stored at room temperature, below 25 °C, in its original container. Keep the product away from moisture and direct sunlight, and ensure the packaging remains sealed until use to maintain stability.

Normofludil is administered orally. The dosage form—typically tablets or oral solution—should be taken with a full glass of water, unless otherwise directed by a healthcare professional. Swallow tablets whole; do not crush or chew unless the product label specifically permits it.

The most serious adverse events include anaphylactic reactions, severe skin disorders such as Stevens‑Johnson syndrome, bronchospasm in susceptible individuals, marked hypotension (especially with intravenous use), and rare cases of hepatic or renal dysfunction. Prompt medical attention is required if any of these occur.

Normofludil should be avoided in patients with known hypersensitivity to acetylcysteine or any excipients in the formulation. Individuals with severe uncontrolled asthma, a history of anaphylaxis, or those taking medications that may cause dangerous interactions (e.g., nitroglycerin) should not use it without close medical supervision.